VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $593,605 (100.0% shares, 0.0% debt)

Holdings (28)

VRDN VIRIDIAN THERAPEUTICS INC 13.3%
Value ($000) $78,863 Shares 2,699,865 Est. Cost $19.47 Unrealized +18.4%
ACRS ACLARIS THERAPEUTICS INC 12.1%
Value ($000) $71,882 Shares 4,563,962 Est. Cost $13.57 Unrealized +18.5%
AXSM AXSOME THERAPEUTICS INC 8.7%
Value ($000) $51,732 Shares 670,718 Est. Cost $59.77 Unrealized 0.0%
COGT COGENT BIOSCIENCES INC 7.9%
Value ($000) $46,681 Shares 4,038,117 Est. Cost $7.95 Unrealized +55.9%
TERN TERNS PHARMACEUTICALS INC 6.4%
Value ($000) $37,746 Shares 3,707,891 Est. Cost $3.72 Unrealized +79.1%
GHRS GH RESEARCH PLC 5.8%
Value ($000) $34,186 Shares 3,517,125 Est. Cost $17.34 Unrealized -37.6%
CELC CELCUITY INC 5.0%
Value ($000) $29,496 Shares 2,105,386 Est. Cost $10.24 Unrealized 0.0%
DICE THERAPEUTICS INC 4.3%
Value ($000) $25,553 Shares 819,000 Est. Cost $21.00 Unrealized
AEROVATE THERAPEUTICS INC 3.7%
Value ($000) $21,913 Shares 747,869 Est. Cost $16.40 Unrealized
PLRX PLIANT THERAPEUTICS INC 3.5%
Value ($000) $20,876 Shares 1,080,000 Est. Cost $19.13 Unrealized +9.3%
KALV KALVISTA PHARMACEUTICALS INC 3.3%
Value ($000) $19,717 Shares 2,916,667 Est. Cost $5.36 Unrealized 0.0%
NVAX NOVAVAX INC 3.3%
Value ($000) $19,325 Shares 1,879,894 Est. Cost $17.65 Unrealized 0.0%
MERUS N V 3.2%
Value ($000) $18,970 Shares 1,226,214 Est. Cost $15.47 Unrealized
CABA CABALETTA BIO INC 3.0%
Value ($000) $17,531 Shares 1,895,285 Est. Cost $3.64 Unrealized 0.0%
ANNX ANNEXON INC 2.8%
Value ($000) $16,648 Shares 3,220,050 Est. Cost $4.00 Unrealized +37.4%
VECTIVBIO HLDG AG 2.7%
Value ($000) $16,169 Shares 1,866,000 Est. Cost $8.66 Unrealized
PROVENTION BIO INC 2.0%
Value ($000) $11,824 Shares 1,118,653 Est. Cost $7.32 Unrealized
SVRA SAVARA INC 1.7%
Value ($000) $9,845 Shares 6,351,531 Est. Cost $1.32 Unrealized +4.1%
MIST MILESTONE PHARMACEUTICALS IN 1.5%
Value ($000) $8,747 Shares 2,208,812 Est. Cost $7.58 Unrealized -30.6%
LIANY LIANBIO 1.3%
Value ($000) $7,861 Shares 4,793,047 Est. Cost $6.16 Unrealized
MARINUS PHARMACEUTICALS INC 1.2%
Value ($000) $7,047 Shares 1,770,705 Est. Cost $11.98 Unrealized
TRVI TREVI THERAPEUTICS INC 1.0%
Value ($000) $5,887 Shares 3,050,022 Est. Cost $2.46 Unrealized -19.8%
FULC FULCRUM THERAPEUTICS INC 0.5%
Value ($000) $3,257 Shares 447,326 Est. Cost $7.16 Unrealized -8.9%
LYRA THERAPEUTICS INC 0.5%
Value ($000) $2,902 Shares 924,170 Est. Cost $5.65 Unrealized
INOZYME PHARMA INC 0.5%
Value ($000) $2,845 Shares 2,709,987 Est. Cost $4.77 Unrealized
ATYR ATYR PHARMA INC 0.4%
Value ($000) $2,565 Shares 1,171,436 Est. Cost $5.98 Unrealized -60.6%
AFFIMED N V 0.3%
Value ($000) $1,771 Shares 1,428,571 Est. Cost $5.52 Unrealized
RALLYBIO CORP 0.3%
Value ($000) $1,764 Shares 268,532 Est. Cost $7.55 Unrealized